ILLUMINA INC (ILMN:NASDAQ)
$131.98 -0.88 (-0.6624%)
Analysed ILLUMINA INC (ILMN:NASDAQ) News Sources
Tempus AI Expands Strategic Partnership Amid Oncology Boom
16-04-2026
yahoo.com
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
16-04-2026
yahoo.com
Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative
15-04-2026
yahoo.com
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
14-04-2026
yahoo.com
Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform
14-04-2026
yahoo.com
Three Best Genomics Stocks for Your Portfolio in 2026
13-04-2026
yahoo.com
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
13-04-2026
yahoo.com
3 Unpopular Stocks That Concern Us
13-04-2026
yahoo.com
Illumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration
12-04-2026
yahoo.com
Is It Time To Reassess Illumina (ILMN) After Its 61.7% One Year Share Price Rebound
11-04-2026
yahoo.com
What is the current price of ILLUMINA INC (ILMN:NASDAQ)?
The current price of ILLUMINA INC (ILMN:NASDAQ) is $131.98.
ILLUMINA INC (ILMN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ILLUMINA INC (ILMN:NASDAQ) since the previous trading day is $-0.88.
ILLUMINA INC (ILMN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ILLUMINA INC (ILMN:NASDAQ) since the previous trading day is -0.6624%.
What is the most recent average sentiment score for ILLUMINA INC (ILMN:NASDAQ)?
The most recent average sentiment score for ILLUMINA INC (ILMN:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for ILLUMINA INC (ILMN:NASDAQ)?
The most recent sentiment for ILLUMINA INC (ILMN:NASDAQ) is .
SEC-8K** Filing Available For ILLUMINA INC (ILMN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.